Frank Mcenulty serves as Executive at Cell MedX Corp., where they oversee executive responsibilities. Since joining the company, Frank Mcenulty has executed 2 insider transactions totaling $130.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 30, 2020 involved purchasing 40,000 shares valued at $10.0K.
Frank Mcenulty currently holds 521,016 shares of Cell MedX Corp. (CMXC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Mcenulty has been a net buyer of CMXC stock. They have purchased $130.3K and sold $0 worth of shares.
Frank Mcenulty's most recent insider trade was on Jul 30, 2020, when they purchased 40,000 shares at $0.25 per share.
Get notified when new Form 4 filings are submitted
| $0.25 |
| Discretionary |